[2P-1053（2AT26-03）] Clodronate attenuates neuropathic and inflammatory pain via inhibition of vesicular nucleotide transporter

〇Yuri Kato^1,2, Miki Hiasa², Reiko Ichikawa³, Nao Hasuzawa⁴, Atsushi Kadowaki⁵, Ken Iwatsuki^3,6, Kazuhiro Shima⁷, Yasuo Endo⁷, Yoshiro Kitahara³, Tsuyoshi Inoue⁵, Masatoshi Nomura⁴, Hiroshi Omote², Yoshinori Moriyama^1,2,8, Takaaki Miyaji¹ (1.Adv. Sci. Res. Cent., Okayama Univ., 2.Dept. of Memb. Biol., Grad. Sch. of Med. Dent. and Pharm. Sci., Okayama Univ., 3.Inst. Innov. Ajinomoto co. Inc., 4.Dept. of Med. and Bio. Sci., Grad. Sch. of Med. Sci., Kyushu Univ., 5.Dept. of Bio. Chem., Grad. Sch. of Med. Dent. and Pharm. Sci., Okayama Univ., 6.Dept. of Nut. Sci. & Food Saf., Tokyo Univ. of Agri., 7.Dept. of Oral Mol. Reg., Grad. Sch. of Dent., Tohoku Univ., 8.Dept. of Bio., Matsumoto Dent. Univ.)

vesicular nucleotide transporter、clodronate、pain、ATP